SECsense Logo

Universe Pharmaceuticals Inc. 6-K Report: Upcoming Shareholder Meeting Insights

$UPC
Form 6-K
Filed on: 2025-02-11
Source
Universe Pharmaceuticals Inc. 6-K Report: Upcoming Shareholder Meeting Insights

Here are the key points extracted from the financial report of Universe Pharmaceuticals Inc. (as per the 6-K filing):

  1. Company Overview: Universe Pharmaceuticals Inc. is incorporated under the laws of the Cayman Islands and is operating from its principal executive office located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji’an, Jiangxi, China.
  2. Event Information:
  • The company distributed a notice of meeting and proxy statement to shareholders regarding an extraordinary general meeting scheduled for February 17, 2025.
  • The meeting will start at 10:00 a.m. Beijing Time.
  1. Meeting Agenda:
  • The shareholders will consider a share capital consolidation proposal.
  • Originally, a consolidation ratio of 15:1 was proposed (the "Original Share Consolidation").
  • The Board has since recommended a Revised Share Consolidation with a ratio between 20:1 and 50:1, giving the Board discretion to choose within this range.
  1. Adjournment of Original Meeting:
  • Due to the planned Revised Meeting on March 1, 2025, the Board will propose at the Original Meeting to indefinitely adjourn the discussions of the Original Meeting.
  1. Exhibits:
  • The filing includes important documents related to the upcoming meetings:
    • Notice and Proxy Statement for the March 2025 meeting.
    • Form of Proxy Card for use by shareholders.
  1. Date of Filing: The report was filed on February 11, 2025.
  2. Signature: The report is signed by Gang Lai, the Chief Executive Officer of Universe Pharmaceuticals Inc.

This summary encapsulates the crucial details regarding the forthcoming shareholder meetings, proposed actions regarding share capital, and relevant administrative updates.